Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia-Reference-Cited by-同舟云学术

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

Published:2015-10-12 Issue:12 Volume:107 Page:djv274
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI.J

Author:

Tseng Yu-Chou,Kulp Samuel K.,Lai I-Lu,Hsu En-Chi,He Wei A.,Frankhouser David E.,Yan Pearlly S.,Mo Xiaokui,Bloomston Mark,Lesinski Gregory B.,Marcucci Guido,Guttridge Denis C.,Bekaii-Saab Tanios,Chen Ching-Shih

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/107/12/djv274/17985950/djv274.pdf

Reference47 articles.

1. Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

2. Cachexia in cancer patients

3. Cachexia as a major underestimated and unmet medical need: facts and numbers

4. Mechanisms of Cancer Cachexia

5. Treating cancer cachexia to treat cancer

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics‐driven discovery of therapeutic targets for cancer cachexia;Journal of Cachexia, Sarcopenia and Muscle;2024-04-21

2. Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia;Ageing Research Reviews;2024-04

3. Transcriptomic signature of cancer cachexia by integration of machine learning, literature mining and meta-analysis;Computers in Biology and Medicine;2024-04

4. Circulating tumor DNA methylation: a promising clinical tool for cancer diagnosis and management;Clinical Chemistry and Laboratory Medicine (CCLM);2024-03-07

5. Transcriptional programming of translation by BCL6 controls skeletal muscle proteostasis;Nature Metabolism;2024-02-09